It is now generally accepted that chronic stimulation of the b-AR/Gas/AC/PKA/CaMKII signaling pathway, as occurs in heart failure via sustained cardiac adrenergic stimulation, can be deleterious to a damaged heart (7). The clinical correlate to this finding is that inhibition of the b-AR signaling pathway by beta-blockers, in conjunction with RAAS inhibition, is the current gold standard of therapy in patients with HFrEF (1, 8) .
A number of studies have dissected the canonical b-AR signaling pathway at multiple levels, demonstrating that overexpression of b 1 -AR (9), Gas (10), PKA (11), and CaMKII (12) can all have deleterious effects. The lone exception to these signaling pathway components is AC, where overexpression of the calcium-inhibitable isoforms is of apparent benefit to compromised cardiac function (13, 14) . Reciprocally, deletion of AC6 (knock out mice) in the face of sustained b-AR stimulation appears to increase mortality (15) . Interestingly, the positive attributes of AC overexpression occur even with a catalytically inactive construct (13) port@ucdenver.edu.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E VOL. 1, NO. 7, 2016 ª 2 0 1 6 T H E A U T H O R S . P U B L I S H E D B Y E L S E V I E R O N B E H A L F O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N . T H I S I S A N O P E N A C C E S S A R T I C L E U N D E R T H E C C B Y -N C -N D L I C E N S E ( h t t p : / / c r e a t i v

